Sionna Therapeutics, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $0Mn |
Net Profits | $-29.89Mn |
Net Profit Margins | -Inf% |
Sionna Therapeutics, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, Sionna Therapeutics, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.
Sionna Therapeutics, Inc. Common Stock’s net profit fell -65.41% since last year same period to $-29.89Mn in the Q2 2026. On a quarterly growth basis, Sionna Therapeutics, Inc. Common Stock has generated -11.6% fall in its net profits since last 3-months.
Sionna Therapeutics, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, Sionna Therapeutics, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.64 |
EPS Estimate Current Year | -0.64 |
Sionna Therapeutics, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a -28% fall from last quarter’s estimates.
Sionna Therapeutics, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -0.64.
Key Ratios
Earning Per Share (EPS) | -0.66 |
Sionna Therapeutics, Inc. Common Stock’s earning per share (EPS) fell -60.98% since last year same period to -0.66 in the Q2 2026. This indicates that the Sionna Therapeutics, Inc. Common Stock has generated -60.98% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-06 | -0.64 | -0.66 | -3.13% |
2026-05-12 | -0.5 | -0.6 | -20% |
